Published on 3 October 2023

Keeping multiresistant pathogens under control

In the last two years SARS-CoV-2 has dominated activity at healthcare facilities. Other challenges, such as preventing and controlling multidrug-resistant organisms (MDRO) and monitoring newly emerging pathogens such as Candida auris, have taken a back seat. Swissnoso has recently published new guidelines for hospitals on these matters.